|
시장보고서
상품코드
1494496
유럽의 혈관 폐쇄 기기 시장 예측(2030년) : 지역별 분석 - 제품 유형, 액세스, 시술, 최종사용자별Europe Vascular Closure Device Market Forecast to 2030 - Regional Analysis - by Product Type, Access, Procedure, and End User |
||||||
유럽의 혈관 폐쇄 기기 시장은 2022년에 3억 6,263만 달러로 평가되며, 2030년에는 6억 2,174만 달러에 달할 것으로 예측되며, 2022-2030년의 CAGR은 7.0%를 기록할 것으로 예측됩니다.
제조업체에 의한 전략적 활동이 유럽의 혈관 폐쇄 기기 시장을 촉진
의료기기 산업은 기술적으로 진보된 제품에 대한 수요 증가로 인해 크게 발전하고 있습니다. 주요 시장 기업은 효율적인 제품 혁신과 개발을 보장하기 위해 신제품 개발, 출시 및 승인에 전념하고 있습니다. 다음은 혈관 폐쇄 기기 시장에서 최근 출시된 제품 출시 및 승인된 제품 중 일부입니다.
지난 9월, Haemonetics Corporation은 VASCADE 및 VASCADE MVP 정맥 혈관 폐쇄 시스템에 대한 CE 마크 인증을 획득했으며, CE 마킹을 통해 두 제품을 유럽연합(EU)에 출시하는 다음 단계에 착수할 수 있게 되었습니다. 2021년 현재 VASCADE MVP는 심방세동(AF) 절제술 후 당일 퇴원할 수 있는 혈관 폐쇄 기기로 FDA 승인을 받은 최초이자 유일한 제품입니다.
2023년 9월, 테르모 메디컬 코퍼레이션(Thermo Medical Corporation)의 크로스실 봉합 혈관 폐쇄 기기 시스템이 FDA의 승인을 받았습니다. 이 장비는 8F-18F 칼집을 사용하여 진단적 또는 중재적 카테터 치료를 받은 환자에서 지혈 시간을 단축하면서 총 대퇴동맥 접근 부위를 폐쇄하기 위해 경피적으로 봉합사를 전달하기 위한 용도로 사용됩니다. 크로스실 시스템은 한쪽 다리의 1개 접근 부위에 적용됩니다. 이러한 전략적 구상은 예측 기간 중 유럽 혈관 폐쇄 기기 시장의 주요 트렌드로 부상할 가능성이 높습니다.
유럽의 혈관 폐쇄 기기 시장 개요
심혈관계 질환은 독일에서 가장 흔한 사망 원인 중 하나입니다. 대중의 생활 습관의 변화가 이 질병의 주요 위험 요소입니다. 심혈관 질환은 독일 사망원인의 40%를 차지하며, 암과 당뇨병이 그 뒤를 잇고 있으며, WHO에 따르면 2020년 독일에서 관상동맥성 심장질환으로 인한 사망자 수는 147,055명(전체 사망자의 20.98%)에 달할 것으로 예상됩니다. 발달된 의료 시설의 존재와 최소 침습적 심장병 수술 증가는 혈관 폐쇄 기기에 대한 수요를 창출하는 요인 중 하나입니다. 킹스 칼리지 런던이 유럽 뇌졸중 연합(Stroke Alliance for Europe)을 위해 작성한 보고서 'Burden of Stroke in Europe'에 따르면 독일에서는 연간 88,922건의 뇌졸중이 발생하며, 이는 인구 10만 명당 52건에 육박합니다. 인구 10만 명당 거의 52명에 해당합니다. 독일의 뇌졸중 유병률은 526,774명으로 인구 10만 명당 338.5명입니다. 또한 연간 75,861명이 뇌졸중으로 사망하고 있으며, 뇌졸중으로 인한 사망률도 높습니다. 유럽의 뇌졸중 부담에 관한 보고서에 따르면 독일의 뇌졸중 환자는 2035년까지 30% 급증하고, 뇌졸중 유병률은 2035년 말까지 19%까지 상승할 것으로 예측했습니다. 이처럼 뇌졸중과 심혈관 질환의 발생률이 크게 증가함에 따라 독일 혈관 폐쇄 기기 시장의 성장을 주도하고 있습니다.
유럽 혈관 폐쇄 기기 시장 매출 및 2030년까지의 예측(금액)
유럽의 혈관 폐쇄 기기 시장 세분화
유럽 혈관 폐쇄 기기 시장은 제품 유형, 접근, 시술, 최종사용자 및 국가별로 분류됩니다.
제품 유형별로 유럽 혈관 폐쇄 기기 시장은 능동형, 수동형, 외부 지혈 장비로 나뉩니다. 패시브 부문이 2022년 가장 큰 점유율을 차지했습니다. 능동적 근사치 부문은 다시 봉합사 개입 장비와 스테이플 클립 개입 장비로 세분화됩니다. 수동적 근사치 부문은 실란트 및 젤 기반, 압박 장비 및 콜라겐 플러그로 세분화됩니다.
접근 방식에 따라 유럽 혈관 폐쇄 기기 시장은 대퇴골 접근과 요골 접근으로 양분되며, 2022년에는 대퇴골 접근 부문이 더 큰 점유율을 차지할 것으로 예상됩니다.
시술별로 유럽 혈관 폐쇄 기기 시장은 중재적 심장학, 중재적 방사선학, 혈관내 수술로 나뉩니다. 중재적 심장학 접근 부문이 2022년 가장 큰 점유율을 차지했습니다.
최종사용자별로 유럽 혈관 폐쇄 기기 시장은 병원, 외래수술센터(ASC), 기타로 분류됩니다. 병원 부문이 2022년 가장 큰 점유율을 차지했습니다.
국가별로 유럽 혈관 폐쇄 기기 시장은 독일, 프랑스, 영국, 이탈리아, 스페인, 기타 유럽으로 구분됩니다. 기타 유럽은 2022년 유럽 혈관폐쇄장비 시장을 장악했습니다.
Abbott Laboratories, Becton Dickinson and Co, Cardinal Health Inc, Cordis Corp, ENDOCOR GmbH &CO KG, Haemonetics Corp, Medtronic Plc, Teleflex Inc, Vasorum Ltd는 유럽의 혈관 폐쇄 기기 시장에서 사업을 운영하고 있는 대기업입니다.
목차
제1장 서론
제2장 주요 요약
- 주요 인사이트
제3장 조사 방법
- 조사 범위
- 2차 조사
- 1차 조사
제4장 유럽의 혈관 폐쇄 기기 시장 - 주요 산업 역학
- 시장 촉진요인
- 심혈관질환의 유병률 증가
- 저침습디바이스에 대한 수요의 급증
- 시장 억제요인
- 혈관 폐쇄 기기에 관한 감염 리스크
- 시장 기회
- 신흥 경제권의 미개척 가능성
- 향후 동향
- 제조업체에 의한 전략적 활동
- 영향 분석
제5장 혈관 폐쇄 기기 시장 : 유럽 시장 분석
- 유럽의 혈관 폐쇄 기기 시장 매출, 2022-2030년
제6장 유럽의 혈관 폐쇄 기기 시장 : 제품 유형별
- 액티브
- 패시브
- 외부 지혈 디바이스
제7장 유럽의 혈관 폐쇄 기기 시장 : 액세스별
- 대퇴골 액세스
- 레이디얼 액세스
제8장 유럽의 혈관 폐쇄 기기 시장 : 시술별
- 중재적 심장학
- 중재적 방사선학
- 혈관내외과
제9장 유럽의 혈관 폐쇄 기기 시장 : 최종사용자별
- 병원
- 외래 수술 센터
- 기타
제10장 유럽의 혈관 폐쇄 기기 시장 : 국가별
- 독일
- 영국
- 프랑스
- 이탈리아
- 스페인
- 기타 유럽
제11장 혈관 폐쇄 기기 시장의 업계 상황
- 혈관 폐쇄 기기 시장에서의 성장 전략
- 무기적 성장 전략
- 유기적 성장 전략
제12장 기업 개요
- Cordis Corp
- Vasorum Ltd
- Haemonetics Corp
- Abbott Laboratories
- Becton Dickinson and Co
- Cardinal Health Inc
- ENDOCOR GmbH & CO KG
- Medtronic Plc
- Teleflex Inc
제13장 부록
KSA 24.06.24The Europe vascular closure device market was valued at US$ 362.63 million in 2022 and is expected to reach US$ 621.74 million by 2030; it is estimated to record a CAGR of 7.0% from 2022 to 2030.
Strategic Activities by Manufacturers Drive Europe Vascular Closure Device Market
The medical device industry is developing significantly due to the increasing demand for technologically advanced products. Major market players engage in new product developments, launches, and approvals to ensure the innovation and development of efficient products. A few of the recent product launches and approvals in the vascular closure devices market are mentioned below.
In September 2022, Haemonetics Corporation obtained CE mark certification for its VASCADE and VASCADE MVP venous vascular closure systems. The CE marking allows Haemonetics to engage in the next steps of launching both products into the European Union (EU); it also allows the company to enter into other geographies that recognize CE marking. As of 2021, VASCADE MVP was the first and only FDA-approved vascular closure device indicated for use following atrial fibrillation (AF) ablation to allow same-day discharge.
In September 2023, a cross-seal, suture-mediated vascular closure device system by Terumo Medical Corporation received approval from the FDA. The device is indicated for the percutaneous delivery of sutures for closing a common femoral artery access site while reducing time-to-hemostasis in patients who have undergone diagnostic or interventional catheterization using 8F to 18F sheaths. The Cross-Seal System is indicated for one access site per leg. Such strategic initiatives are likely to emerge as a key trend in the Europe vascular closure device market during the forecast period.
Europe Vascular Closure Device Market Overview
Cardiovascular disorders are among the most common causes of death in Germany. Changing lifestyles among the masses is a major risk factor for this disease. Cardiovascular disorders account for ~40% of deaths in Germany, followed by cancer and diabetes. According to the WHO, the death toll due to coronary heart disease in Germany reached 147,055 (i.e., 20.98% of total mortalities) in 2020. The presence of developed healthcare facilities and the increasing number of minimally invasive cardiology procedures are among the factors that are likely to create demand for vascular closure devices. According to data published in the Burden of Stroke in Europe report prepared by King's College London for the Stroke Alliance for Europe, Germany records ~88,922 stroke cases annually, which is equivalent to nearly 52 cases per 100,000 inhabitants. The total prevalence of stroke in Germany was 526,774, which accounts for 338.5 strokes per 100,000 residents. Germany also has a significant mortality rate of stroke as it reports 75,861 deaths due to stroke per year. According to the Burden of Stroke in Europe report, stroke cases in Germany are likely to surge by 30% by 2035, while the prevalence of stroke is anticipated to rise to 19% by the end of 2035. Thus, the significantly growing incidence of stroke and cardiovascular disorder drives the vascular closure devices market growth in Germany.
Europe Vascular Closure Device Market Revenue and Forecast to 2030 (US$ Million)
Europe Vascular Closure Device Market Segmentation
The Europe vascular closure device market is segmented based on product type, access, procedure, end user, and country.
Based on product type, the Europe vascular closure device market is segmented into active approximators, passive approximators, and external hemostatic devices. The passive approximators segment held the largest share in 2022. The active approximators segment is further segmented into suture mediated device and staple clips mediated device. The passive approximators segment is further segmented into sealant and gel based, compression devices, and collagen plug.
By access, the Europe vascular closure device market is bifurcated into femoral access and radial access. The femoral access segment held a larger share in 2022.
By procedure, the Europe vascular closure device market is segmented into interventional cardiology, interventional radiology, and endovascular surgery. The interventional cardiology access segment held the largest share in 2022.
In terms of end user, the Europe vascular closure device market is categorized into hospitals, ambulatory surgical centers, and others. The hospitals segment held the largest share in 2022.
Based on country, the Europe vascular closure device market is segmented into Germany, France, the UK, Italy, Spain, and the Rest of Europe. The Rest of Europe dominated the Europe vascular closure device market in 2022.
Abbott Laboratories, Becton Dickinson and Co, Cardinal Health Inc, Cordis Corp, ENDOCOR GmbH & CO KG, Haemonetics Corp, Medtronic Plc, Teleflex Inc, and Vasorum Ltd are some of the leading companies operating in the Europe vascular closure device market.
Table Of Contents
1. Introduction
- 1.1 The Insight Partners Research Report Guidance
- 1.2 Market Segmentation
2. Executive Summary
- 2.1 Key Insights
3. Research Methodology
- 3.1 Coverage
- 3.2 Secondary Research
- 3.3 Primary Research
4. Europe Vascular Closure Device Market - Key Industry Dynamics
- 4.1 Market Drivers
- 4.1.1 Increasing Prevalence of Cardiovascular Diseases
- 4.1.2 Burgeoning Demand for Minimally Invasive Devices
- 4.2 Market Restraints
- 4.2.1 Risk of Infection Related to Vascular Closure Devices
- 4.3 Market Opportunities
- 4.3.1 Untapped Potential of Emerging Economies
- 4.4 Future Trends
- 4.4.1 Strategic Activities by Manufacturers
- 4.5 Impact Analysis:
5. Vascular Closure Device Market - Europe Market Analysis
- 5.1 Europe Vascular Closure Device Market Revenue (US$ Mn), 2022 - 2030
6. Europe Vascular Closure Device Market - Revenue and Forecast to 2030 - by Product Type
- 6.1 Overview
- 6.2 Europe Vascular Closure Device Market Revenue Share, by Product Type 2022 & 2030 (%)
- 6.3 Active Approximators
- 6.3.1 Overview
- 6.3.2 Active Approximators: Europe Vascular Closure Device Market - Revenue and Forecast to 2030 (US$ Million)
- 6.3.2.1 Active Approximators: Europe Vascular Closure Device Market - Revenue and Forecast to 2030 (US$ Million)
- 6.4 Passive Approximators
- 6.4.1 Overview
- 6.4.2 Passive Approximators: Europe Vascular Closure Device Market - Revenue and Forecast to 2030 (US$ Million)
- 6.4.2.1 Passive Approximators: Europe Vascular Closure Device Market - Revenue and Forecast to 2030 (US$ Million)
- 6.5 External hemostatic devices
- 6.5.1 Overview
- 6.5.2 External hemostatic devices: Europe Vascular Closure Device Market - Revenue and Forecast to 2030 (US$ Million)
7. Europe Vascular Closure Device Market - Revenue and Forecast to 2030 - by Access
- 7.1 Overview
- 7.2 Europe Vascular Closure Device Market Revenue Share, by Access 2022 & 2030 (%)
- 7.3 Femoral Access
- 7.3.1 Overview
- 7.3.2 Femoral Access: Europe Vascular Closure Device Market - Revenue and Forecast to 2030 (US$ Million)
- 7.4 Radial Access
- 7.4.1 Overview
- 7.4.2 Radial Access: Europe Vascular Closure Device Market - Revenue and Forecast to 2030 (US$ Million)
8. Europe Vascular Closure Device Market - Revenue and Forecast to 2030 - by Procedure
- 8.1 Overview
- 8.2 Europe Vascular Closure Device Market Revenue Share, by Procedure 2022 & 2030 (%)
- 8.3 Interventional Cardiology
- 8.3.1 Overview
- 8.3.2 Interventional Cardiology: Europe Vascular Closure Device Market - Revenue and Forecast to 2030 (US$ Million)
- 8.4 Interventional Radiology
- 8.4.1 Overview
- 8.4.2 Interventional Radiology: Europe Vascular Closure Device Market - Revenue and Forecast to 2030 (US$ Million)
- 8.5 Endovascular Surgical
- 8.5.1 Overview
- 8.5.2 Endovascular Surgical: Europe Vascular Closure Device Market - Revenue and Forecast to 2030 (US$ Million)
9. Europe Vascular Closure Device Market - Revenue and Forecast to 2030 - by End Users
- 9.1 Overview
- 9.2 Europe Vascular Closure Device Market Revenue Share, by End Users 2022 & 2030 (%)
- 9.3 Hospitals
- 9.3.1 Overview
- 9.3.2 Hospitals: Europe Vascular Closure Device Market - Revenue and Forecast to 2030 (US$ Million)
- 9.4 Ambulatory Surgical Center
- 9.4.1 Overview
- 9.4.2 Ambulatory Surgical Center: Europe Vascular Closure Device Market - Revenue and Forecast to 2030 (US$ Million)
- 9.5 Others
- 9.5.1 Overview
- 9.5.2 Others: Europe Vascular Closure Device Market - Revenue and Forecast to 2030 (US$ Million)
10. Europe Vascular Closure Device Market - Country Analysis
- 10.1.1.1 Europe Vascular Closure Device Market by Country
- 10.1.1.2 Germany
- 10.1.1.2.1 Overview
- 10.1.1.2.2 Germany: Europe Vascular Closure Device Market Revenue and Forecast to 2030 (US$ Mn)
- 10.1.1.2.3 Germany: Europe Vascular Closure Device Market, by Product Type
- 10.1.1.2.3.1 Germany: Europe Vascular Closure Device Market, by Active Approximators, 2020-2030 (US$ Million)
- 10.1.1.2.3.2 Germany: Europe Vascular Closure Device Market, by Passive Approximators , 2020-2030 (US$ Million)
- 10.1.1.2.4 Germany: Europe Vascular Closure Device Market, by Access
- 10.1.1.2.5 Germany: Europe Vascular Closure Device Market, by Procedure
- 10.1.1.2.6 Germany: Europe Vascular Closure Device Market, by End Users
- 10.1.1.3 UK
- 10.1.1.3.1 Overview
- 10.1.1.3.2 UK: Europe Vascular Closure Device Market Revenue and Forecast to 2030 (US$ Mn)
- 10.1.1.3.3 UK: Europe Vascular Closure Device Market, by Product Type
- 10.1.1.3.3.1 UK: Europe Vascular Closure Device Market, by Active Approximators, 2020-2030 (US$ Million)
- 10.1.1.3.3.2 UK: Europe Vascular Closure Device Market, by Passive Approximators , 2020-2030 (US$ Million)
- 10.1.1.3.4 UK: Europe Vascular Closure Device Market, by Access
- 10.1.1.3.5 UK: Europe Vascular Closure Device Market, by Procedure
- 10.1.1.3.6 UK: Europe Vascular Closure Device Market, by End Users
- 10.1.1.4 France
- 10.1.1.4.1 Overview
- 10.1.1.4.2 France: Europe Vascular Closure Device Market Revenue and Forecast to 2030 (US$ Mn)
- 10.1.1.4.3 France: Europe Vascular Closure Device Market, by Product Type
- 10.1.1.4.3.1 France: Europe Vascular Closure Device Market, by Active Approximators, 2020-2030 (US$ Million)
- 10.1.1.4.3.2 France: Europe Vascular Closure Device Market, by Passive Approximators , 2020-2030 (US$ Million)
- 10.1.1.4.4 France: Europe Vascular Closure Device Market, by Access
- 10.1.1.4.5 France: Europe Vascular Closure Device Market, by Procedure
- 10.1.1.4.6 France: Europe Vascular Closure Device Market, by End Users
- 10.1.1.5 Italy
- 10.1.1.5.1 Overview
- 10.1.1.5.2 Italy: Europe Vascular Closure Device Market Revenue and Forecast to 2030 (US$ Mn)
- 10.1.1.5.3 Italy: Europe Vascular Closure Device Market, by Product Type
- 10.1.1.5.3.1 Italy: Europe Vascular Closure Device Market, by Active Approximators, 2020-2030 (US$ Million)
- 10.1.1.5.3.2 Italy: Europe Vascular Closure Device Market, by Passive Approximators , 2020-2030 (US$ Million)
- 10.1.1.5.4 Italy: Europe Vascular Closure Device Market, by Access
- 10.1.1.5.5 Italy: Europe Vascular Closure Device Market, by Procedure
- 10.1.1.5.6 Italy: Europe Vascular Closure Device Market, by End Users
- 10.1.1.6 Spain
- 10.1.1.6.1 Overview
- 10.1.1.6.2 Spain: Europe Vascular Closure Device Market Revenue and Forecast to 2030 (US$ Mn)
- 10.1.1.6.3 Spain: Europe Vascular Closure Device Market, by Product Type
- 10.1.1.6.3.1 Spain: Europe Vascular Closure Device Market, by Active Approximators, 2020-2030 (US$ Million)
- 10.1.1.6.3.2 Spain: Europe Vascular Closure Device Market, by Passive Approximators , 2020-2030 (US$ Million)
- 10.1.1.6.4 Spain: Europe Vascular Closure Device Market, by Access
- 10.1.1.6.5 Spain: Europe Vascular Closure Device Market, by Procedure
- 10.1.1.6.6 Spain: Europe Vascular Closure Device Market, by End Users
- 10.1.1.7 Rest of Europe
- 10.1.1.7.1 Overview
- 10.1.1.7.2 Rest of Europe: Europe Vascular Closure Device Market Revenue and Forecast to 2030 (US$ Mn)
- 10.1.1.7.3 Rest of Europe: Europe Vascular Closure Device Market, by Product Type
- 10.1.1.7.3.1 Rest of Europe: Europe Vascular Closure Device Market, by Active Approximators, 2020-2030 (US$ Million)
- 10.1.1.7.3.2 Rest of Europe: Europe Vascular Closure Device Market, by Passive Approximators , 2020-2030 (US$ Million)
- 10.1.1.7.4 Rest of Europe: Europe Vascular Closure Device Market, by Access
- 10.1.1.7.5 Rest of Europe: Europe Vascular Closure Device Market, by Procedure
- 10.1.1.7.6 Rest of Europe: Europe Vascular Closure Device Market, by End Users
11. Vascular Closure Device Market Industry Landscape
- 11.1 Overview
- 11.2 Growth Strategies in the Vascular Closure Devices Market
- 11.3 Inorganic Growth Strategies
- 11.3.1 Overview
- 11.4 Organic Growth Strategies
- 11.4.1 Overview
12. Company Profiles
- 12.1 Cordis Corp
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Products and Services
- 12.1.4 Financial Overview
- 12.1.5 SWOT Analysis
- 12.1.6 Key Developments
- 12.2 Vasorum Ltd
- 12.2.1 Key Facts
- 12.2.2 Business Description
- 12.2.3 Products and Services
- 12.2.4 Financial Overview
- 12.2.5 SWOT Analysis
- 12.2.6 Key Developments
- 12.3 Haemonetics Corp
- 12.3.1 Key Facts
- 12.3.2 Business Description
- 12.3.3 Products and Services
- 12.3.4 Financial Overview
- 12.3.5 SWOT Analysis
- 12.3.6 Key Developments
- 12.4 Abbott Laboratories
- 12.4.1 Key Facts
- 12.4.2 Business Description
- 12.4.3 Products and Services
- 12.4.4 Financial Overview
- 12.4.5 SWOT Analysis
- 12.4.6 Key Developments
- 12.5 Becton Dickinson and Co
- 12.5.1 Key Facts
- 12.5.2 Business Description
- 12.5.3 Products and Services
- 12.5.4 Financial Overview
- 12.5.5 SWOT Analysis
- 12.5.6 Key Developments
- 12.6 Cardinal Health Inc
- 12.6.1 Key Facts
- 12.6.2 Business Description
- 12.6.3 Products and Services
- 12.6.4 Financial Overview
- 12.6.5 SWOT Analysis
- 12.6.6 Key Developments
- 12.7 ENDOCOR GmbH & CO KG
- 12.7.1 Key Facts
- 12.7.2 Business Description
- 12.7.3 Products and Services
- 12.7.4 Financial Overview
- 12.7.5 SWOT Analysis
- 12.7.6 Key Developments
- 12.8 Medtronic Plc
- 12.8.1 Key Facts
- 12.8.2 Business Description
- 12.8.3 Products and Services
- 12.8.4 Financial Overview
- 12.8.5 SWOT Analysis
- 12.8.6 Key Developments
- 12.9 Teleflex Inc
- 12.9.1 Key Facts
- 12.9.2 Business Description
- 12.9.3 Products and Services
- 12.9.4 Financial Overview
- 12.9.5 SWOT Analysis
- 12.9.6 Key Developments
13. Appendix
- 13.1 About Us
- 13.2 Glossary of Terms
